Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.6 CNY -0.5%
Market Cap: 50.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Gross Margin
Hangzhou Tigermed Consulting Co Ltd

38%
Current
41%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
38%
=
Gross Profit
2.7B
/
Revenue
7B

Gross Margin Across Competitors

Country CN
Market Cap 50.1B CNY
Gross Margin
38%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 207B USD
Gross Margin
41%
Country US
Market Cap 174.4B USD
Gross Margin
60%
Country KR
Market Cap 67.6T KRW
Gross Margin
50%
Country CH
Market Cap 40.2B CHF
Gross Margin
29%
Country US
Market Cap 38.4B USD
Gross Margin
35%
Country US
Market Cap 38.6B USD
Gross Margin
55%
Country US
Market Cap 26.7B USD
Gross Margin
59%
Country US
Market Cap 24.9B USD
Gross Margin
35%
Country US
Market Cap 23.3B USD
Gross Margin
64%

Profitability Report

View the profitability report to see the full profitability analysis for Hangzhou Tigermed Consulting Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
38%
=
Gross Profit
2.7B
/
Revenue
7B
What is the Gross Margin of Hangzhou Tigermed Consulting Co Ltd?

Based on Hangzhou Tigermed Consulting Co Ltd's most recent financial statements, the company has Gross Margin of 38%.